24.12.2014 Views

to download - ALLSA

to download - ALLSA

to download - ALLSA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

lasting up <strong>to</strong> 4 hours. If these are required frequently,<br />

the patient should seek medical help. During an acute<br />

attack, in lieu of a nebuliser, an SAB2, via MDI plus<br />

spacer may be used (20 puffs for adults and 10 puffs<br />

for children – one puff at a time). If there is no improvement<br />

refer <strong>to</strong> doc<strong>to</strong>r for possible oral steroids. Longacting<br />

β 2 -agonists (salmeterol or formoterol), should<br />

only be used in conjunction with inhaled corticosteroids<br />

(ICS), and never administered <strong>to</strong> preschoolers. Sideeffects<br />

include tremor, palpitations, headaches and<br />

facial flushing. In the case of under-2-year-olds and<br />

the elderly, ipratropium bromide (e.g. Ipvent) may be<br />

prescribed. Beneficial effects are noted 30-40 minutes<br />

after administration and side-effects include dry mouth<br />

and constipation.<br />

Explain the actions of controllers<br />

Identify specific device <strong>to</strong> be used and the dose required<br />

(budesonide, fluticasone propionate or beclomethasone).<br />

Explain that if taken regularly, every morning<br />

and every evening, the inflammation in the airways<br />

which causes asthma symp<strong>to</strong>ms will be reduced and<br />

this in turn should reduce the severity and frequency of<br />

acute attacks. Patients should not s<strong>to</strong>p until they next<br />

see their doc<strong>to</strong>r, even though symp<strong>to</strong>ms are not present.<br />

Side-effects are rare but may include hoarseness<br />

or oral thrush. This may be overcome by using a spacer<br />

or regular rinsing of the mouth, after each ICS administration.<br />

Reassure patients that corticosteroids used for<br />

asthma are different from anabolic steroids used by athletes.<br />

The appropriate device should be demonstrated<br />

and checked. Always have a placebo available and<br />

demonstrate the device yourself, then ask patient <strong>to</strong> do<br />

so. Watch closely and discuss any concerns. Correct<br />

technique with inhaler is essential and adherence vital.<br />

Tables I and II and Figure 1 illustrate and outline device<br />

techniques and care.<br />

An emergency action plan should be written down,<br />

taking in<strong>to</strong> account the patient’s lifestyle. Printed action<br />

plans are available at www.asthma.co.za<br />

Discuss a self-management plan. This should include<br />

the nature of asthma and how the patient can recognise<br />

signs and symp<strong>to</strong>ms of worsening asthma. These<br />

include deterioration in peak flow (if meter is used), increase<br />

in diurnal variations, an increase in symp<strong>to</strong>ms<br />

with more frequent use of bronchodila<strong>to</strong>rs, yet declining<br />

efficacy of same. Sleep disturbance and a decrease in<br />

exercise <strong>to</strong>lerance should also be recognised as signs of<br />

impending asthma deterioration. In addition, the patient<br />

should be <strong>to</strong>ld (and the plan written down) what action<br />

<strong>to</strong> take and where <strong>to</strong> go – even in the middle of the<br />

night, when <strong>to</strong> start prednisolone, how much, and how<br />

<strong>to</strong> avoid triggers (including smoking). Asthma symp<strong>to</strong>m<br />

and adherence diary available at www.asthma.co.za<br />

Finally, and most importantly, make a follow-up appointment.<br />

On all subsequent follow-up visits adherence<br />

(how many times did you forget your medication),<br />

inhaler technique evaluation, and an exploration<br />

of possible different health beliefs and/or psychological<br />

issues should be addressed in order <strong>to</strong> achieve optimal<br />

control.<br />

CONCLUSION<br />

A trained enthusiastic allergy and asthma nurse can<br />

work <strong>to</strong>gether with the health team and patients in order<br />

<strong>to</strong> strive for improved control and quality of life for<br />

all patients.<br />

THE FUTURE<br />

It would be a great advantage <strong>to</strong> have an allergy course<br />

where nurses can be trained as allergy nurse practitioners,<br />

who will work in conjunction with allergists and<br />

also function at primary health clinics where specialists<br />

are not always available. They could work in pathology<br />

services where they can conduct basic allergy tests,<br />

e.g. skin-prick tests. These allergy nurse practitioners<br />

would also provide patient education in areas beyond<br />

specialist clinics and assist doc<strong>to</strong>rs <strong>to</strong> refer patients <strong>to</strong><br />

the specialised centres when necessary.<br />

Acknowledgement<br />

We thank the authors of the National Asthma Education Programme<br />

Version 2011 which has been used for this article.<br />

We thank Prof Paul Potter for his invaluable assistance in the preparation<br />

of this article.<br />

Declaration of conflict of interest<br />

The authors declare no conflict of interest.<br />

References<br />

1. Lalloo U, Ainslie G, Wong M, et al. Guidelines for the management<br />

of asthma in adults and adolescents. South African Family Practice<br />

2007; 49 (5): 19-31.<br />

2. Motala C, Green RJ, Manjra AI, et al. Guideline for the management<br />

of chronic asthma in children - 2009 update. S Afr Med J 2009; 99:<br />

897-912.<br />

3. Kling S, Goussard P, Gie RP. Treatment of acute asthma in children.<br />

Current Allergy & Clinical Immunology 2011; 24: 22-26.<br />

4. Green RJ, Motala C, Potter PC, eds. <strong>ALLSA</strong> Handbook of Practical<br />

Allergy, 3rd ed. Cape Town: <strong>ALLSA</strong>, 2010: 17.<br />

Would you like <strong>to</strong> receive future copies of this journal<br />

Please contact our national office <strong>to</strong> be added <strong>to</strong> the mailing list.<br />

If you are interested in becoming a member of the Allergy Society of South Africa (<strong>ALLSA</strong>),<br />

please contact Mrs Ruwayda Adams for more details.<br />

<strong>ALLSA</strong> Office<br />

PO Box 88<br />

Observa<strong>to</strong>ry 7935<br />

Tel 021-447-9019<br />

Fax 021-448-0846<br />

Email mail@allergysa.org<br />

144 Current Allergy & Clinical Immunology, August 2011 Vol 24, No.3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!